EMD Serono Inc., Merck KGaA’s North American drug development business, has officially taken up residence in Boston’s Seaport ...

Merck and Siemens have signed a strategic partnership to accelerate digital transformation in manufacturing through smart, ...

The efficacy of rucaparib plus nivolumab was compared with rucaparib monotherapy as maintenance treatment for ovarian cancer.

MS experts are recommending updates to the 2017 McDonald diagnostic criteria that aim to make diagnosis easier, faster and more accurate.

Further confirmatory data will be necessary to maintain its approval in the US, where it will be co-marketed by EMD Serono, German Merck’s US biopharma business, and Pfizer. The drug was ...

Development methodologies combine old and new techniques, but getting any new material into high-volume manufacturing is a ...

EMD Serono, the biopharmaceutical division of Germany’s Merck KGaA, said approval was based on the phase 3 JAVELIN Bladder 100 study meeting its primary endpoint of overall survival at the ...

The combination of belrestotug and dostarlimab significantly improved response rates in patients with previously untreated ...

This marks Keytruda's first approval for the given indication. Merck (MRK) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...